T cell-mediated lethal shock triggered in mice by the super-antigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor

Journal of Experimental Medicine

Volumn 175, Issue 1, 1992, Pages 91-98

  Miethke, Thomas ^a   Wahl, Claudia ^a   Heeg, Klaus ^a   Echtenacher, Bernd ^a,b   Krammer, Peter H ^a,b   Wagner, Hermann ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; LIPOPOLYSACCHARIDE; LYMPHOKINE; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PATHOGENESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TOXIC SHOCK SYNDROME;

ANIMAL; CELLS, CULTURED; DEATH; ENTEROTOXINS; FLOW CYTOMETRY; GALACTOSAMINE; INTERLEUKIN-2; LIPOPOLYSACCHARIDES; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; SHOCK, SEPTIC; STAPHYLOCOCCUS AUREUS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR;

EID: 0026596020     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.175.1.91     Document Type: Article

References (39)

1. Morrison, D.C., and J.L. Ryan. 1987. Endotoxins and disease mechanisms. Anm. Rev. Med. 38:417.
2. Wolff, S.M., and J.V. Benett. 1974. Gram negative rod bacter-aemia (editorial). N. Engl. J. Med. 291:733.
3. Freudenberg, M.A., D. Keppler, and C. Galanos. 1986. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect. Immun. 51:891.
4. Tracey, K.J., Y. Fong, D.G. Hesse, K.R. Manogue, A.T. Lee, G.C. Kuo, S.F. Lowry, and A. Cerami. 1987. Anti-cachectin/ TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (Lond.). 330:662.
5. Bergdoll, M.S. 1979. Staphylococcal intoxications. In Food Bourne Infections and Intoxications. H. Riemann, and F.L. Bryon, editors. Academic Press, New York. 443-494.
6. Schlievert, P.M., K.N. Shands, B.B. Dan, G.P. Schmid, and R.D. Nishimura. 1981. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J. Infect. Dis. 143:509.
7. Spero, L., A. Jonson-Winger, and J.J. Schmidt. 1988. Enterotoxins of Staphylococci. In Handbook of Natural Toxins. C.M. Hardgree, and A.T. Tu, editors, Marcel Dekker, Inc., New York. 131-163.
8. Peavy, D.L., W.H. Adler, and R.T. Smith. 1970. The mito-genic effects of endotoxin and Staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes. J. Immunol. 105:1453.
9. Janeway, C.A., Jr., J. Yagi, PJ. Conrad, M.E. Katz, B. Jones, S. Vroegop, and S. Buxser. 1989. T-cell responses to Mis and to bacterial proteins that mimic its behavior. Immunol. Rev. 107:61.
10. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science (Wish. DC). 248:705.
11. Fleischer, B., and H. Schrezenmeier. 1988. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J. Exp Med. 167:1697.
12. White, J., A. Herman, A.M. Pullen, K. Rubo, J.W. Kappler, and P. Marrack. 1989. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 56:27.
13. Cosimir, A.B., R.B. Colvin, R.C. Burton, R.H. Rubin, G. Goldstein, P.C. Krug, P. Hausen, F.L. Delminco, and P.S. Russel. 1981. Use of monoclonal antibodies to T cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N. Engl. J. Med. 305:308.
14. Chatenoud, L., C. Ferran, A. Reuter, C. Legendre, Y. Gevaert, H. Kreis, P. Franchimont, and J.F. Bach. 1989. Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma. N. Engl. f. Med. 320:1420.
15. Galanos, C., M.A. Freudenberg, and W. Reutter. 1979. Galactosmine-induced sensitization of the lethal effects of endotoxin. Proc Natl. Acad. Sei. USA. 76:5939.
16. Lehmann, V., M.A. Freudenberg, and G. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp Med. 165:657.
17. Goding, J.W. 1986. Immunofluorescence. In Monoclonal Antibodies: Principles and Practice. Harcourt Brace Jovanovich Publications, New York. 255-265.
18. Echtenacher, B., W. Falk, D.N. Mannel, and P.H. Krammer. 1990. Requirement of endogenous tumor necrosis factorJ cachectin for recovery from experimental peritonitis.J. Immunol 145:3762.
19. Heeg, K., J. Reimann, D. Kabelitz, C. Hardt, and H. Wagner. 1985. A rapid colorimetric assay for the determination of IL-2 producing helper T cell frequencies. J. Immunol. Methods. 77:237.
20. Bunjes, D., C. Hardt, M. Röllinghoff, and H. Wagner. 1981. Cyclosporin A mediates immunosuppression of primary cytotoxic T lymphocytes by impairment release of interleukin I and interleukin 2. Eur. J. Immunol. 11:657.
21. Crass, B.A., and M.S. Bergdoll. 1986. Toxin involvement in toxic shock syndrome. J. Infect. Dis. 153:918.
22. Marrack, P., M. Blackman, E. Kushnir, and J. Kappler. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp Med. 171:455.
23. Bergdoll, M.S., B.A. Crass, R.F. Reiser, R.N. Robbins, and J.P. Davies. 1981. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome staphylococcal aureus isolates. Lancet. 1:1017.
24. Parsonnet, J. 1989. Mediators in the pathogenesis of toxic shock syndrome: overview. Rev. Infect. Dis. 2(Suppl 1):S263.
25. Uchiyama, T., Y. Kamagata, M. Wakai, M. Yoshioka, H. Fujikawa, and H. Igarashi. 1986. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin. Microbiol. Immunol. 30:469.
26. Jupin, C., S. Anderson, C. Damais, J.E. Alouf, and M. Parant. 1988. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factor and y interferon.J. Exp Med. 167:752.
27. Galelli, A., S. Anderson, B. Chariot, and J.E. Alouf. 1989. Induction of murine hemopoietic growth factors by toxic shock syndrome toxin-1. J. Immunol 142:2855.
28. Ikejima, T., C.A. Dinarello, D.M. Gill, and S.M. Wolff. 1984. Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome. J. Clin Invest. 73:1312.
29. Fast, D.J., P.M. Schlievert, and R.D. Nelson. 1989. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Inject. Immun. 57:291.
30. Rosenberg, S.A., M.T. Lotze, and J.J. Mule. 1988. NIH conference. New approaches to the immunotherapy of cancer using interleukin-2. Ann. Intern. Med. 108:853.
31. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF-a primary mediator of the host response. Annu. Rev. Immunol. 7:625.
32. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. 1989. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between Interleukin 6, Interleukin 1, and Fatal Outcome. J. Exp Med. 169:333.
33. Cuturi, M.C., M. Murphy, M.P. Costa-Giomi, R. Weinmann, B. Perussia, and G. Trinchieri. 1987. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J. Exp Med. 165:1581.
34. Beutler, B., I.W. Milsark, and A.C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science (Wash. DC). 229:869.
35. Gardner, S.M., B.A. Mock, J. Hilgers, K.E. Huppi, and W.D. Roeder. 1987. Mouse lymphotoxin and tumor necrosis factor: structural analysis of the cloned genes, physical linkage, and chromosomal position. J. Immunol. 139:476.
36. Paul, N.L., and N.H. Ruddle. 1988. Lymphotoxin. Annu. Rev. Immunol. 6:407.
37. Waage, A., A. Halstensen, and T. Espevik. 1987. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1:355.
38. Gramm, H., A. Lindenman, R. Mertelsmann, and F. Hermann. 1991. Phase I trial of rec. human TNFa in patients with advanced malignancy. Eur. J. Cancer. In press.
39. Waage, A., and T Espevik. 1988. Interleukin 1 potentiates the lethal effect of tumor necrosis factor of J cachectin in mice. J. Exp Med. 167:1987.